BeiGene Latest Chinese Biotech To Double Down On mRNA For Cancer
Executive Summary
Chinese biotechs have reached deals for cancer therapies to explore the novel uses of messenger RNA technology beyond COVID-19 vaccines, as the mRNA COVID-19 vaccine fame starts fading.